ROBIN SHERRINGTON (EVP, Strategy & Innovation) reported 1 transaction at XENON PHARMACEUTICALS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/2/2024ACC: 0000950170-24-000304
Officer· EVP, Strategy & Innovation
Since Sep 2019
-8.40K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
8.40K disposed
Non-Derivative Transactions1
Common Shares
Direct
Shares
−8.40K
Price / share
—
Trade value
—
% of position
50.0%
12/29/2023
16.80K→8.40K
Total
Net shares
−8.40K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 12/29/2023 | J · J | −8.40K | — | — | 50.0% | 16.80K | 8.40K |
| Total | −8.40K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported